Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Oct 4, 2026, 9:01 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 49–72 of 114 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Electrophysiology Clear all

Conditions: Major Depressive Disorder
Interventions: Directional Deep Brain Stimulation; Device
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 22 Years to 70 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2027
U.S. locations: 2
States / cities: Dallas, Texas • Houston, Texas

Conditions: Subarachnoid Hemorrhage
Interventions: Esmolol; Drug
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Coronary Artery Disease, Electrophysiology, Cardiovascular Disease
Interventions: Not listed
Lead sponsor: Intermountain Health Care, Inc.; Other
Eligibility: 18 Years and older
Enrollment: 30,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1994 – 2027
U.S. locations: 1
States / cities: Murray, Utah

Conditions: LAMA2-MD (Merosin Deficient Congenital Muscular Dystrophy, MDC1A)
Interventions: Not listed
Lead sponsor: Cure CMD; Other
Eligibility: Not listed
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: San Pedro, California

Conditions: Venous Vascular Closure, Electrophysiology Study
Interventions: MYNX CONTROLTM VENOUS Vascular Closure Device; Device
Lead sponsor: Cordis US Corp.; Industry
Eligibility: Not listed
Enrollment: 339 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 9
States / cities: Los Angeles, California • Palo Alto, California • Littleton, Colorado + 6 more

Conditions: Incomplete Spinal Cord Injury, Spasticity, Muscle
Interventions: Motor Skill Training (MST), Transcutaneous Spinal Stimulation (TSS); Behavioral · Device
Lead sponsor: Shepherd Center, Atlanta GA; Other
Eligibility: 18 Years to 70 Years
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Brain Injuries
Interventions: Transcranial Magnetic Stimulation (TMS), Sham TMS; Device · Other
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 85 Years
Enrollment: 64 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2023
U.S. locations: 2
States / cities: Atlanta, Georgia

Conditions: Parkinson's Disease (PD)
Interventions: Novel neural recorder; Device
Lead sponsor: University of Minnesota; Other
Eligibility: 22 Years to 75 Years
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Coronary Artery Disease
Interventions: Not listed
Lead sponsor: Holy Cross Hospital, Florida; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Fort Lauderdale, Florida

Conditions: Atrial Fibrillation (AF), Persistent Atrial Fibrillation, Paroxysmal Atrial Fibrillation (PAF)
Interventions: Sphere-9 Catheter Ablation; Device
Lead sponsor: Medtronic Cardiac Ablation Solutions; Industry
Eligibility: 18 Years and older
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 22
States / cities: Birmingham, Alabama • La Jolla, California • Los Angeles, California + 19 more

Conditions: Glaucoma, Macular Disease
Interventions: Not listed
Lead sponsor: Wills Eye; Other
Eligibility: 18 Years and older
Enrollment: 5,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2000 – 2029
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Implanted With Any Currently (and Any Future) FDA-approved Medtronic ICD or CRT Device, to Which is Attached a St. Jude Riata Lead
Interventions: fluoroscopy, synchronized high-voltage shock, Holter monitor; Procedure
Lead sponsor: Hartford Hospital; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2019
U.S. locations: 1
States / cities: Hartford, Connecticut

Conditions: Anesthesia
Interventions: No Intervention Used; Other
Lead sponsor: University Hospitals Cleveland Medical Center; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Electrophysiology Study, Ablation
Interventions: Peritorq; Device
Lead sponsor: University of Minnesota; Other
Eligibility: Up to 21 Years
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 2
States / cities: Washington D.C., District of Columbia • Minneapolis, Minnesota

Conditions: Aortic Stenosis, Heart Block, Aortic Insufficiency
Interventions: Electrophysiology Study; Diagnostic Test
Lead sponsor: Henry Ford Health System; Other
Eligibility: 18 Years and older
Enrollment: 126 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Cardiac Electrophysiology
Interventions: Tetanizing Burst Therapy; Device
Lead sponsor: EP Sciences; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Equipment and Supplies
Interventions: X-Trodes acquisition system; Device
Lead sponsor: B-Cube; Other
Eligibility: 21 Years and older
Enrollment: 57 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Fetal Arrhythmia
Interventions: fetal MCG; Device
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years and older · Female only
Enrollment: 450 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2028
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Schizophrenia
Interventions: ANAVEX3-71 oral capsules, Placebo oral capsules; Drug
Lead sponsor: Anavex Life Sciences Corp.; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 71 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Marlton, New Jersey

Conditions: Cardiac Arrhythmia
Interventions: Electrophysiology procedure; Device
Lead sponsor: CathVision ApS; Industry
Eligibility: 18 Years and older
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Burlington, Vermont

Conditions: Atrial Fibrillation
Interventions: KODEX - EPD; Device
Lead sponsor: University of Arizona; Other
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: Alcohol Use Disorder
Interventions: Acamprosate calcium, Placebo; Drug · Other
Lead sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA); NIH
Eligibility: 21 Years to 65 Years
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Binge Drinking
Interventions: Resonance breathing, Low demand cognitive task; Behavioral
Lead sponsor: Rutgers, The State University of New Jersey; Other
Eligibility: 18 Years to 35 Years
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: New Brunswick, New Jersey

Conditions: Healthy
Interventions: Placebo, AV-101 720 mg, AV-101 1440 mg; Drug
Lead sponsor: Marijn Lijffijt, PhD; Other
Eligibility: 18 Years to 64 Years
Enrollment: 18 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Houston, Texas

Search by objective public record fields.

DBS for Depression

Study to Evaluate Esmolol (Brevibloc) to Manage Cardiac Function in Patients With Subarachnoid Hemorrhage

Database Registry of the Intermountain Heart Collaborative Study

LAMA2-related Muscular Dystrophy Brain Study

Mobilization and Outcomes After Venous Closure

Activating Spinal Circuits to Improve Walking, Balance, Strength, and Reduce Spasticity

Cortical Contributions to Motor Sequence Learning

Novel DBS Device in Parkinson's Disease

The Holding Area LINQ (Reveal LINQ Insertable Cardiac Monitor) Trial is a Prospective, Non-randomized, Single Center Post-market Clinical Trial

Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sphere-9 Catheter and Affera Ablation System (Conquer-AF)

Novel Glaucoma Diagnostics

Insulation Failure in St. Jude Riata Leads

Anesthesia Charting Fidelity Study

Torque Device Evaluation

Conduction Disease After Transcatheter Aortic Valve Replacement

Study to Evaluate Tetanizing Burst Therapy in Patients Undergoing ICD Replacement

Evaluation of Accuracy and Consistency of the X-Trodes System

Electrophysiology of Fetal Arrhythmia

A Study of ANAVEX3-71 in Adults With Schizophrenia

An Evaluation of the Safety and Performance of the CathVision ECGenius® System.

All Inclusive Kodex - EPD Study

Temporally-Resolved Electrophysiology of Acamprosate Treatment of Alcohol Use Disorder

Afferent Neurocardiac Signals, Cue Reactivity, and Cognitive Control

Electrophysiological Biomarkers of AV-101